These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 396767)

  • 21. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 22. A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection.
    Sireci G; Barera A; Macaluso P; Di Sano C; Bonanno CT; Pio La Manna M; Di Liberto D; Dieli F; Salerno A
    Immunobiology; 2009; 214(8):703-11. PubMed ID: 19249121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of phytohaemagglutinin on skin graft survival in mice.
    Kowalczyk K; Kulig M; Plonka I; Rablin J
    Folia Biol (Krakow); 1974; 22(4):439-47. PubMed ID: 4611811
    [No Abstract]   [Full Text] [Related]  

  • 25. Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice.
    Coates PT; Krishnan R; Kireta S; Johnston J; Russ GR
    Gene Ther; 2001 Aug; 8(16):1224-33. PubMed ID: 11509955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basis of impaired graft rejection of aging NZB-W mice.
    Gelfand MC; Steinberg AD
    Transplant Proc; 1973 Mar; 5(1):145-8. PubMed ID: 4572091
    [No Abstract]   [Full Text] [Related]  

  • 27. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow origin of nonsensitized effector cells in skin allograft rejection.
    Kongshavn PA; Lapp WS
    Transplantation; 1973 Oct; 16(4):382-4. PubMed ID: 4583154
    [No Abstract]   [Full Text] [Related]  

  • 29. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-lymphocyte and cytokine-directed strategies for inhibiting skin allograft rejection in mice.
    Vossen AC; Tibbe GJ; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):380-2. PubMed ID: 7879028
    [No Abstract]   [Full Text] [Related]  

  • 31. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cellular infiltrate in skin allografts in mice.
    Rothwell TL; Papadimitriou JM
    J Pathol; 1972 Aug; 107(4):235-43. PubMed ID: 4576943
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mixed lymphocyte reaction. Detection of single histocompatibility loci and the correlation to skin graft survival in mice.
    Mangi RJ; Mardiney MR
    Transplantation; 1971 Apr; 11(4):369-73. PubMed ID: 4934347
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo treatment of mice with heat shock protein, gp 96, improves survival of skin grafts with minor and major antigenic disparity.
    Kovalchin JT; Mendonca C; Wagh MS; Wang R; Chandawarkar RY
    Transpl Immunol; 2006 Jan; 15(3):179-85. PubMed ID: 16431284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the mechanism of lymphokine production and release.
    Korcáková L; Smetana K; Svobodová J
    Folia Biol (Praha); 1980; 26(2):140-4. PubMed ID: 6155295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative data concerning the development of the cellular infiltration of skin allograft in mice.
    Jakóbisiak M
    Transplantation; 1971 Nov; 12(5):364-7. PubMed ID: 4948687
    [No Abstract]   [Full Text] [Related]  

  • 40. A lymphatic approach to tissue injury.
    Lewis GP
    N Engl J Med; 1975 Aug; 293(6):287-91. PubMed ID: 1094292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.